<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>78(2)</volume><submitter>Yang MM</submitter><funding>Rheumatology Research Foundation</funding><funding>Scleroderma Research Foundation</funding><pubmed_abstract>&lt;h4>Objective&lt;/h4>Peripheral blood leukocyte telomere length (PBL-TL) shortening is associated with systemic sclerosis-related interstitial lung disease (SSc-ILD). However, its association with other organ involvement, disease severity, and survival remains unclear. This study aimed to define the relationship of TL with SSc-specific disease manifestations and outcomes.&lt;h4>Methods&lt;/h4>PBL-TL was measured by quantitative polymerase chain reaction in 244 patients with SSc and 314 healthy controls. Multivariate modeling was used to assess the association of PBL-TL with disease severity and event-free survival. Longitudinal changes in PBL-TL were measured in a subset of patients. TL was quantified in SSc skin and lung tissues by telomere fluorescence in situ hybridization.&lt;h4>Results&lt;/h4>PBL-TL</pubmed_abstract><journal>Arthritis &amp; rheumatology (Hoboken, N.J.)</journal><pagination>428-437</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12936899</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis.</pubmed_title><pmcid>PMC12936899</pmcid><pubmed_authors>Yang MM</pubmed_authors><pubmed_authors>Lee S</pubmed_authors><pubmed_authors>French S</pubmed_authors><pubmed_authors>Boin F</pubmed_authors><pubmed_authors>Liu S</pubmed_authors><pubmed_authors>Wax M</pubmed_authors><pubmed_authors>Wolters PJ</pubmed_authors></additional><is_claimable>false</is_claimable><name>Telomere Length of Peripheral Blood Leukocytes Predicts Disease Severity and Worse Survival in Systemic Sclerosis.</name><description>&lt;h4>Objective&lt;/h4>Peripheral blood leukocyte telomere length (PBL-TL) shortening is associated with systemic sclerosis-related interstitial lung disease (SSc-ILD). However, its association with other organ involvement, disease severity, and survival remains unclear. This study aimed to define the relationship of TL with SSc-specific disease manifestations and outcomes.&lt;h4>Methods&lt;/h4>PBL-TL was measured by quantitative polymerase chain reaction in 244 patients with SSc and 314 healthy controls. Multivariate modeling was used to assess the association of PBL-TL with disease severity and event-free survival. Longitudinal changes in PBL-TL were measured in a subset of patients. TL was quantified in SSc skin and lung tissues by telomere fluorescence in situ hybridization.&lt;h4>Results&lt;/h4>PBL-TL</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-16T21:58:15.553Z</modification><creation>2026-07-11T03:08:46.124Z</creation></dates><accession>S-EPMC12936899</accession><cross_references><pubmed>40964771</pubmed><doi>10.1002/art.43400</doi></cross_references></HashMap>